Literature DB >> 27669666

Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases.

Zhiqiang Ma1, Chao Deng2, Wei Hu3, Jie Zhou4, Chongxi Fan5, Shouyin Di5, Dong Liu6, Yang Yang1, Dongjin Wang1.   

Abstract

Liver X receptors α (LXRα) and β (LXRβ) are essential for protection against cardiovascular diseases. LXRs are members of the nuclear receptor superfamily of DNA-binding transcription factors and act as sensors of cholesterol homeostasis. In this review, we introduce LXRs and briefly describe the roles of LXRs in reverse cholesterol transport and trans-intestinal cholesterol efflux. We discuss LXR agonists and the downstream genes of LXRs that are involved in the regulation of cholesterol transport. In addition, we describe the cardioprotective effects of LXRs against atherosclerosis, myocardial ischemia/reperfusion injury, diabetic cardiomyopathy, and myocardial hypertrophy. Finally, we expand our discussion to the actions of LXRs in atherosclerosis and suggest several potential research avenues that may be of interest to clinicians and basic scientists. The information included herein may be useful for the design of future experimental research studies and may advance the investigation of LXRs as therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27669666     DOI: 10.21775/cimb.022.041

Source DB:  PubMed          Journal:  Curr Issues Mol Biol        ISSN: 1467-3037            Impact factor:   2.081


  21 in total

Review 1.  Role of Liver X Receptor in Mastitis Therapy and Regulation of Milk Fat Synthesis.

Authors:  Xiaoyu Hu; Naisheng Zhang; Yunhe Fu
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-31       Impact factor: 2.673

2.  Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages.

Authors:  Mithila Vaidya; Julian A Jentsch; Susann Peters; Petra Keul; Sarah Weske; Markus H Gräler; Emil Mladenov; George Iliakis; Gerd Heusch; Bodo Levkau
Journal:  J Lipid Res       Date:  2019-01-17       Impact factor: 5.922

3.  LXRs regulate features of age-related macular degeneration and may be a potential therapeutic target.

Authors:  Mayur Choudhary; Ebraheim N Ismail; Pei-Li Yao; Faryan Tayyari; Roxana A Radu; Steven Nusinowitz; Michael E Boulton; Rajendra S Apte; Jeffrey W Ruberti; James T Handa; Peter Tontonoz; Goldis Malek
Journal:  JCI Insight       Date:  2020-01-16

Review 4.  Adenosine and the Cardiovascular System.

Authors:  Allison B Reiss; David Grossfeld; Lora J Kasselman; Heather A Renna; Nicholas A Vernice; Wendy Drewes; Justin Konig; Steven E Carsons; Joshua DeLeon
Journal:  Am J Cardiovasc Drugs       Date:  2019-10       Impact factor: 3.571

5.  Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages.

Authors:  Brett McGettigan; Rachel McMahan; David Orlicky; Matthew Burchill; Thomas Danhorn; Prashanth Francis; Lin Ling Cheng; Lucy Golden-Mason; Claudia V Jakubzick; Hugo R Rosen
Journal:  Hepatology       Date:  2019-02-27       Impact factor: 17.298

6.  Hepatic Transporter Alterations by Nuclear Receptor Agonist T0901317 in Sandwich-Cultured Human Hepatocytes: Proteomic Analysis and PBPK Modeling to Evaluate Drug-Drug Interaction Risk.

Authors:  Katsuaki Ito; Noora Sjöstedt; Melina M Malinen; Cen Guo; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2020-03-03       Impact factor: 4.030

Review 7.  The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease.

Authors:  Michael B Fessler
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

8.  Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells.

Authors:  Haojun Xiong; Yan Zhang; Shan Chen; Zhenhong Ni; Jintao He; Xinzhe Li; Bo Li; Kai Zhao; Fan Yang; Yijun Zeng; Bingbo Chen; Fengtian He
Journal:  Oncotarget       Date:  2017-07-18

9.  Liver X Receptor Agonist Therapy Prevents Diffuse Alveolar Hemorrhage in Murine Lupus by Repolarizing Macrophages.

Authors:  Shuhong Han; Haoyang Zhuang; Stepan Shumyak; Jingfan Wu; Chao Xie; Hui Li; Li-Jun Yang; Westley H Reeves
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

10.  miR-33 inhibition attenuates the effect of liver X receptor agonist T0901317 on expression of liver X receptor alpha in mice liver.

Authors:  Abbas Mohammadi; Hossein Fallah; Beydolah Shahouzehi; Hamid Najafipour
Journal:  ARYA Atheroscler       Date:  2017-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.